HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
Treating Anemia in CKD in the Era of HIFs: A Ray of Hope? - Renal Fellow Network
Mechanism of action of HIF stabilizers. Under normal conditions, the... | Download Scientific Diagram
Hypoxia-inducible factor - Wikipedia
Anemia of Chronic Kidney Disease: Will New Agents Deliver on Their Promise?
The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease - Kidney International
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis - ScienceDirect
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics | Pediatric Nephrology
Cureus | An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients | Article
a, b HIF activity under normoxic/ hypoxic conditions and HIF-PHI... | Download Scientific Diagram
Edgar V. Lerma 🇵🇠on X: "AGARWAL: HIF stabilizers - safety concerns #Nephpearls #NKFClinicals https://t.co/v82n2tAusp" / X
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects | Clinical and Experimental Nephrology
HIF prolyl-hydroxylase inhibitor - Wikipedia
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Molecules | Free Full-Text | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
![PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/954f37aaed4c29d5041d58192b31cdf86184379a/2-Figure1-1.png "PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar")
PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar
HIF-1 as a target for drug development | Nature Reviews Drug Discovery
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease pat
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
HIF Stabilizers Get in Sync: Are ESAs Bye Bye Bye? in: Kidney News Volume 13 Issue 3 (2021)
The pro-angiogenic role of hypoxia inducible factor stabilizer FG-4592 and its application in an in vivo tissue engineering chamber model | Scientific Reports
Hif ph inhibitors for anemia in ckd | PPT
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury - ScienceDirect
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
HIF PHI Trials in CKD non-dialysis and dialysis: What do the data really show?
